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We compared irisin levels among groups of differently trained healthy individuals to explore the role of irisin as a physiological
linker between exercise and metabolic health. Irisin and biochemical parameters of glucose and lipid metabolism were assessed in
70 healthy volunteers stratified for sport performance level into four groups: (1) 20 elite athletes of national level, (2) 20 subelite
athletes of local level, (3) 20 recreational athletes, and (4) 10 sedentary subjects. All biochemical parameters were within the ranges
of normality. Fasting glucose, HOMA-IR, and total cholesterol levels were inversely related to the degree of physical activity. HbA1c
was higher in elite athletes compared to all the other groups (𝑝 < 0.01). A U-shaped relation between free fatty acids and the degree
of physical activity was observed. All groups showed similar plasma irisin levels. After correction for the degree of insulin resistance
(irisin/HOMA-IR), elite athletes showed higher levels compared to sedentary and recreational subjects (𝑝 < 0.01 and 𝑝 < 0.05,
resp.). In addition, the number of metabolic parameters correlated with irisin increased at increasing the training status. Our study
suggests a correlation between sport performance, insulin sensitivity, and irisin levels. Irisin may be one potential mediator of the
beneficial effects of exercise on metabolic profile.
1. Introduction
The role of physical activity in maintaining good health
and preventing insulin resistance, type 2 diabetes mellitus
(DMT2), obesity, metabolic syndrome, atherosclerosis, and
other cardiovascular complications is well recognized [1–3].
The protective effect of physical activity may be ascribed,
to some extent, to the release of myokines from contracting
skeletal muscles. These molecules, in fact, may mediate the
beneficial effects of exercise on glucose and lipid metabolism
and on inflammation, which characterizes both metabolic
and cardiovascular diseases [4]. An interesting editorial by
Polyzos and colleagues highlighted the possibility that irisin
in humans could be a link between physical activity and
metabolic homeostasis and could be implicated in processes
involved in weight balance [5].
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Irisin is amyokine firstly identified for its ability to induce
browning of white adipose tissue, to increase energy expendi-
ture and to protect against insulin resistance and obesity [6].
The beneficial effects of exercise on bonemetabolism seem to
bemediated by different myokines as irisin [7].The real effect
of physical activity in promoting expression and secretion of
irisin in human is still unclear. In fact, besides some studies
which described a great effect of exercise in promoting irisin
increase [8–10], other studies reported that neither acute
nor chronic exercise promotes changes in irisin level [11–14].
Probably,most of these controversiesmay depend on the type
of exercise (resistance/endurance), its duration (acute/pro-
longed), the training status of individuals before enrollment
in the studies, and the type of assay for irisin quantification.
A review published in 2014 explains that different studies
in humans have shown inconsistent results related to the pro-
posed induction of irisin by exercise [15]. Human studies till
now performed were almost interventional studies aimed to
evaluate acute changes in irisin level after a training program.
The relationship among the sporting behavior and chronic
irisin level is poorly explored, instead.
To this aim, we compared irisin level among groups of
differently trained healthy individuals (elite athletes of inter-
national and national level, athletes of local level, recreational
athletes, and sedentary individuals) and we explored the
role of irisin as a physiological linker between exercise and
metabolic health.
2. Methods
2.1. Aim. The purpose of this work is to compare irisin level
among groups of differently trained healthy individuals (elite
athletes of international and national level, athletes of local
level, recreational athletes, and sedentary individuals) and to
explore the role of irisin as a physiological linker between
exercise and metabolic health.
2.2. Design and Setting of the Study. All subjects involved in
this protocol were admitted to the UO Endocrinology after
an overnight fast and before any exercise activity. At 08.00, a
polyethylene catheter was inserted into the antecubital vein of
one forearm. At 08.30, a basal blood sample for the measure-
ment of hormones and metabolites was drawn. Weight and
heightwere then recordedwith standard scales and stadiome-
ters and BMI was calculated. Then the subjects were dis-
charged.
2.3. Biochemical Assays. Blood samples were collected after
overnight fasting into pyrogen-free tubes with EDTA as
anticoagulant or in tubes for serum separation. Plasma and
serum samples were prepared by centrifugation at 4∘Cwithin
1.5 h of sampling and aliquots were frozen at −20∘C until later
analyses.
Fasting glucose, glycated hemoglobin (HbA1c), insulin,
total cholesterol, and triglycerides were quantified with com-
mercial kits using Cobas 6000 analyzer (Roche Diagnostics,
Milan, Italy), as previously reported [16, 17]. Briefly, total
cholesterol has been determined by an enzymatic-colorimet-
ric method. The lower detection limit was 3.86mg/dL. Intra-
and interassay coefficient of variations (CV%) were 1.1% and
1.6%, respectively.The hexokinase method was used to quan-
tify glucose.The lower detection limitwas 2mg/dL. Intra- and
interassayCV%were 1.0% and 1.3%, respectively. Turbidimet-
ric inhibition immunoassay method was used for the deter-
mination of HbA1c. Lower detection limit was 0.18mmol/L.
Intra- and interassay CV% were 1.6% and 2.0%, respec-
tively. Triglycerides were quantified using an enzymatic-
colorimetric method. Lower detection limit was 8.85mg/dL.
Intra- and interassay CV% were 1.1% and 2.0%, respectively.
Insulin was measured by electrochemiluminescent immuno-
assay. The lower detection limit was 0.2𝜇U/mL. Intra- and
interassay CV% were 1.5% and 4.9%, respectively. Free fatty
acids (NEFA) were quantified on a Uvikon analyzer using
the colorimetric method provided by Randox Laboratories
(Crumlin, County Antrim, UK). The method is linear up to
2.24mmol/L. The minimum detectable level with acceptable
precision has been determined at 0.072mmol/L. Within run
assay CV% and total assay CV% were 4.81% and 4.51%,
respectively.
2.4. Irisin Quantification. Circulating irisin levels have been
quantified on serum samples by a specific competitive
enzyme immunoassay kit which has been previously validated
by MS spectrometry analysis (Cat. EK-067-29, Phoenix
EuropeGmbH,Karlsruhe,Germany).Theminimumdetecta-
ble concentration was 1.43 ng/mL. The intra- and interassay
variationswere less than 10% and 15%, respectively.The assays
used to detection of irisin were previously validated [18].
2.5. HOMA-IR. Insulin action was assessed using the equa-
tions provided by HomeOstasis Model Assessment for esti-
mating insulin resistance (HOMA-IR): HOMA-IR = 𝐺0 ⋅
𝐼0/22.5, where 𝐼0 (𝜇U/mL) is the fasting insulin concentra-
tion, 𝐺0 (mmol/L) is the fasting glucose concentration, and
22.5 represents a constant applied to correct the value to unity
as previously described [19].
2.6. Characteristics of Participant. In a case-control study, we
studied 4 groups of healthy subjects who routinely perform
different levels of aerobic physical activity (elite athletes
of international and national level, athletes of local level,
recreational athletes, and sedentary subjects). Elite athlete is
defined as a highly specialized athlete whose performances
correspond to the best national results in his or her respective
sports or discipline. Athlete of local level is a subject who
trains at least 4 times a week for a total of at least 10 hours per
week. Subjects who performed recreational physical activity
are defined as subjects who train at least 2 times a week for a
total of at least 3 hours per week. The sedentary is a subject
who does not perform any train session in the week and does
not perform physical exercise during habitual work.
All the subjects recruited for the study gave their
informed written consent after being given an explanation of
purposes and nature of the experimental protocol, conducted
in accordance with the declaration of Helsinki, as revised in
2013.
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2.7. Ethics Approval andConsent to Participate. Thestudywas
approved by the ethics committee of Ospedale San Raffaele,
reference number: 88/int/2016. All the subjects recruited
for the study gave their informed written consent after
being given an explanation of purposes and nature of the
experimental protocol. All procedures performed in studies
involving human participants were in accordance with the
ethical standards of the institutional and/or national research
committee andwith the 1964Helsinki declaration and its later
amendments or comparable ethical standards.
2.8. Statistical Analysis. All statistical analyses and graphi-
cal data representations were done using GraphPad Prism
5.0 biochemical statistical package (GraphPad Software,
San Diego, CA). Data are expressed as mean ± SD. The
Kolmogorov-Smirnoff test was used to assess the normality
of data distribution. Comparisons between groups were
performed using ANOVA or Kruskal-Wallis tests followed by
Bonferroni or Dunn’s posttests, as appropriate.The univariate
associations between irisin, demographic, anthropometric,
and biochemical parameters were examined by Pearson or
Spearman correlation tests. A 𝑝 value < 0.05 was considered
significant.
3. Results
3.1. Anthropometric Parameters of the Participants, Group Size,
and Gender. Of the 70 subjects enrolled for the study 20
were elite athletes [17 males and 3 females, age 22.4 ± 2.8
mean ± standard deviation (SD), and bodymass index (BMI)
22.4±1.7Kg/m2], 20 were athletes of local level [15 males and
5 females, age 21.2 ± 2.1mean ± SD, BMI 22.4 ± 2.4Kg/m2],
20 were recreational [13 males and 7 females, age 24.6 ± 8.1
mean ± SD, BMI, 22.1 ± 2.7Kg/m2], and 10 were sedentary
individuals [6 males and 4 females, age 25.2 ± 8.1 mean ±
SD, BMI, 22.8 ± 2.8Kg/m2]. Total physical activity score of
participants was classified as inactive (less than 600 MET
minutes per week), recreational (between 600 and 3000MET
minutes per week), subelite (between 3000 and 4000 MET
minutes per week), and elite (more than 4000 MET minutes
perweek) according to recommendations in the International
Physical Activity Questionnaire (IPAQ) [20].
3.2. GlucoseMetabolism. Fasting glucose, HbA1c, and insulin
levels were within the normal ranges in all groups. Fasting
glucose was higher in the sedentary group compared to
both elite and subelite groups (𝑝 < 0.01 and 𝑝 < 0.05,
resp.) (Figure 1). No statistically significant differences were
detected in fasting insulin levels among the groups, although
a trend of increasemay be observed at decreasing the training
status (Figure 1). To be noted, in sedentary, the HOMA-
IR was higher compared to both elite and subelite groups
(𝑝 < 0.05 for both), thus suggesting a mild insulin resistance
status (Figure 1). HbA1c was increased only in elite athletes
compared to all the other groups (𝑝 < 0.01 for all).
3.3. Lipid Profile. Plasma lipid profile was normal in all
groups. Total cholesterol was higher in sedentary group than
the others (𝑝 < 0.05, for all). Triglycerides were similar
in all the four groups. In contrast, nonesterified fatty acids
(NEFA) were higher in sedentary and elite groups compared
to recreational (𝑝 < 0.01 for all) (Figure 1).
3.4. Irisin. All groups showed similar plasma irisin level.
After irisin correction for the degree of insulin resistance
(irisin/HOMA-IR) elite and subelite athletes showed signifi-
cantly increased ratios compared both to sedentary (𝑝 < 0.01
for elite and𝑝 < 0.05 for subelite) and to recreational subjects
(𝑝 < 0.05, for both) (Figure 2).The associations among irisin,
demographic, anthropometric, and biochemical parameters
were explored using Pearson or Spearman correlation coef-
ficients. For this analysis elite and subelite athletes were
considered jointly because these parameters are very similar
in these two groups. An increased number of correlations
among irisin and biochemical parameters were observed at
increasing the training status. In sedentary group, it was only
one direct correlation between irisin and irisin/HOMA-IR
ratio (Table 1). In recreational group, irisin was also inversely
associated with fasting glucose (Table 1). In elite/subelite
group, 3 further inverse correlationswere observed: with total
cholesterol, triglycerides, and free fatty acid (Table 1).
4. Discussion
It has been suggested that the myokine irisin could play an
endocrine control of metabolism in the humans. Irisin level
seems to be negatively correlated with age, insulin concen-
trations, triglyceride, and adiponectin levels, suggesting that
this hormone may be involved in mechanisms for metabolic
regulation. In particular in the study of Huh and colleagues
an acute bout of vibration exercise increases circulating irisin,
whereas chronic training does not change the values of irisin
in humans [21]. Another study of this group shows exercise-
induced irisin secretion independently of age or fitness level
[22]. In our study, we evaluated the concentrations of irisin in
a population of athletes who regularly performdifferent loads
of physical activity and we did not find significant differences
in the basal concentrations of this hormone in the different
groups studied. These data seem to be similar to results of
another study performed on adolescent athletes in a paper of
Singhal and colleagues [23]. In this study irisin was compared
in two groups (eumenorrheic athletes and nonathletes, resp.)
in amenorrheic athletes. The data about irisin in the same
condition in eumenorrheic athletes and nonathletes were
similar in these groups [23]. Another study showed that 12
weeks of heavy strength training is not able to increase serum
irisin levels inwomen [24]. In contrast a study showed, during
an endurance exercise routine in sedentary men, a twofold
rise in plasma irisin levels at ten weeks [6], while another
study in adults reported an increase in irisin following acute
exercise, but a decrease in irisin after a 12-week of endurance
and strength training [25].
Previous studies focused on insulin resistance [26, 27]
assumed that this condition may represent an indepen-
dent risk factor affecting the circulating levels of different
molecules, that is, adipokines, and suggested the use of the
adjusted ratio as amoremetabolically relevantmeasure. Since
also in our study HOMA-IR is the main parameter that
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Figure 1: Fasting glucose, insulin, glycated hemoglobin (HbA1c), total cholesterol, triglycerides, free fatty acids (NEFA) levels, and
HomeOstasis Model Assessment for estimating insulin resistance (HOMA-IR) values in differently trained subjects. Fasting glucose, insulin,
HbA1c, total cholesterol, triglycerides, NEFA levels, and HOMA-IR values were evaluated in elite (E), subelite (SE), recreational (R), and
sedentary (S) subjects. ∗𝑝 < 0.05; ∗∗𝑝 < 0.01.
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Figure 2: Irisin and irisin/HomeOstasis Model Assessment for estimating insulin resistance (HOMA-IR) ratio levels in differently trained
subjects. Irisin and irisin/HOMA-IR ratios were evaluated in elite (E), subelite (SE), recreational (R), and sedentary (S) subjects. ∗𝑝 < 0.05;
∗∗𝑝 < 0.01.
changes more between the different groups, we hypothesized
that insulin resistance could affect irisin values and we
decided to include also the adjusted ratio (irisin/HOMA-IR)
as a new independent parameter. Notably, differently from
irisin, whose levels were not different among groups, values
of irisin/HOMA-IR were significantly increased when com-
pared to sedentary and recreational subjects, thus confirming
a potential influence of insulin resistance on irisin levels.
In our study HOMA-IR correlate inversely with the
degree of physical activity (in particular there is a strict
correlation between insulin sensitivity and METS expressed
as MET minutes per week, 𝑝 < 0.001); logically in subjects
that do more physical activities HOMA-IR values are lower
and also the values of absolute irisin seem to be high; although
not reaching significance this hormone shows a trend of
higher values in subjects that perform more physical activity
as elite and subelite athletes versus sedentary (10.6±5.1 versus
8.4±4.5 ng/mL).Despite not showing a statistically significant
difference these data are interesting and suggest the presence
of a “memory” of physical activity performed.
Here are not current data on irisin in elite athletes in
literature. The possibility of analyzing irisin on subjects with
a high load of exercise (>11 METS: Metabolic Equivalent of
Task) is critical to understand the real correlation between
this myokine and physical activity.
Another study highlights a significant decrease of irisin
in type 2 diabetic subjects compared to nonobese controls
[28]; in particular the irisin values found in the lean control
subjects are comparable to those found in our group of
sedentary subjects.
A recent study showed that irisin concentrations of the
endurance trained athletes were higher than that of the
sedentary control subjects [29].
At baseline values irisin seems to increase or not different
in insulin resistance models such as polycystic ovary syn-
drome (PCOS) as reported by recent papers [30, 31].
The numerous works in the literature cited in the dis-
cussion often have not adequate control group and therefore
the findings of these paper must be interpreted and partially
downsized in their conclusions.
The values of irisin could be more closely related to
insulin sensitivity of peripheral tissues and in particular with
striatedmuscle and this difference seems to be detectable also
in basal condition, independently of physical activity per-
formed in acute exercise. In fact, irisin is amyokine produced
by striated muscle and the muscle’s ability to modulate the
input of energy substrates in the muscle is essential to main-
tain glucose homeostasis.
In fact, inverse correlation between irisin and blood
glucose in subjects who performed physical exercises seems
to indicate a direct action of irisin on glucose metabolism. In
addition high values of HbA1c in elite athletes have already
been described in another paper [32] and seem to correlate
with increased endogenous glucose production during exer-
cise and secondary to exogenous implementation during and
after the performance.The euglycemia that is present in these
athletes at rest is probably also mediated by irisin.
Moreover, the presence of lower values of circulating
lipids (total cholesterol, triglycerides, andNEFA) in the group
of subjects who performed more hours of physical training
also indicates amodulatory role of irisin on lipidmetabolism.
In particular the possibility of developing a form of
“irisin-resistance” linked to the increase in insulin resistance
may in part explain the high levels of this hormone in
obese subjects and in women with PCOS, while, as already
mentioned above, in elite athletes the value of irisin may
remain slightly elevated as a “memory” of physical exercise
performed in the previous day.
In fact, the absence of changes in irisin values in women
with PCOS after taking therapy with metformin suggests,
at least in this condition of insulin resistance, a different
mechanism of myokine increases [33].
In conclusion our data indicate a possible key role of irisin
on glucose and lipid metabolism in health young people,
which is reflected on high value of ratio irisin/HOMA-IR in
the group of athletes who perform more exercise.
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Table 1: Univariate association between plasma irisin level and
demographic, anthropometric, and biochemical parameters in dif-
ferently trained individuals: (a) elite + subelite group, (b) recre-
ational group, and (c) sedentary group.
(a) Elite and subelite
𝑟 𝑝
Age(2) −0.16 0.336
BMI(1) −0.11 0.512
Fasting glucose(2) −0.477 0.003
Fasting insulin(2) −0.058 0.730
Total cholesterol(1) −0.329 0.047
Triglycerides(2) −0.441 0.006
NEFA(2) −0.545 0.001
HbA1c(1) −0.206 0.221
HOMA-IR(2) −0.065 0.698
Irisin/HOMA-IR(2) 0.633 <0.0001
(b) Recreational
𝑟 𝑝
Age(2) −0.667 0.967
BMI(1) 0.268 0.090
Fasting glucose(1) −0.306 0.006
Fasting insulin(2) 0.142 0.399
Total cholesterol(1) 0.004 0.792
Triglycerides(2) −0.137 0.411
NEFA(1) 0.075 0.66
HbA1c(1) −0.139 0.413
HOMA-IR(2) 0.203 0.203
Irisin/HOMA-IR(2) 0.603 <0.0001
(c) Sedentary
𝑟 𝑝
Age(2) −0.278 0.436
BMI(1) −0.217 0.548
Fasting glucose(1) 0.103 0.777
Fasting insulin(2) 0.395 0.333
Total cholesterol(1) 0.09 0.803
Triglycerides(2) 0.4001 0.251
NEFA(1) −0.134 0.752
HbA1c(1) −0.601 0.087
HOMA-IR(2) 0.288 0.419
Irisin/HOMA-IR(2) 0.833 0.003
Associations between variables were explored using Pearson or Spearman
correlation coefficients, as appropriate. (1)Pearson correlation; (2)Spearman
correlation.
BMI, bodymass index; NEFA, free fatty acids; HbA1c, glycated hemoglobin;
HOMA-IR, HomeOstasis Model Assessment for estimating insulin resis-
tance.
It will need additional studies with a larger number of
subjects to better understand the mechanisms that regulate
the production of irisin during different levels of physical
activity.
5. Study Limitations
There are some possible limitations to consider in the present
study. First, the number of subjects in the sample is somewhat
small. Second, this is a case-control study and the power
analysis of sample size cannot draw a cause-effect conclusion
about irisin and insulin sensitivity in elite athletes. Further
large studies are needed to elucidate the real role of irisin in
modulation of insulin sensitivity in humans.
Moreover in some papers cited as references it is not
entirely clear whether the blood sample for irisin assay was
performed immediately after exercise or after a fewhours; this
could be a confounding factor that may partially justify the
contradictory data.
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